Technologies Trageting Mitochondral Proteome

Information

  • Research Project
  • 6992797
  • ApplicationId
    6992797
  • Core Project Number
    R43AG026859
  • Full Project Number
    1R43AG026859-01
  • Serial Number
    26859
  • FOA Number
    PA-04-64
  • Sub Project Id
  • Project Start Date
    9/1/2005 - 19 years ago
  • Project End Date
    2/28/2007 - 17 years ago
  • Program Officer Name
    FINKELSTEIN, DAVID B.
  • Budget Start Date
    9/1/2005 - 19 years ago
  • Budget End Date
    2/28/2007 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/22/2005 - 19 years ago

Technologies Trageting Mitochondral Proteome

DESCRIPTION (provided by applicant): Mitochondria have a variety of essential responsibilities in cellular metabolism, e.g. the production of ATP through oxidative phosphorylation in aerobic cells as well as the initiation of the signal cascade leading to apoptosis. Alteration of the mitochondrial proteome and altered mitochondrial function have been implicated in a variety of degenerative diseases, heart disease, aging, and cancer. Because the mitochondria are a major source of endogenously generated reactive oxygen species (ROS), it is not surprising that they have been proposed to play a major role in aging. The free radical theory of aging predicts that oxidative damage to the mitochondria can lead to an amplifying effect whereby damaged mitochondria release more ROS, further increasing oxidative damage. Considering the progressive age-dependent functional changes of most cell types and tissues, an accurate profile of age-dependent mitochondria proteome is mandatory and will shed light on the molecular mechanisms and pathways of age-associated disease processes. To greatly increase the mitochondria proteome coverage, particularly toward the identification of post-translational modifications (PTMs), this project aims to develop and demonstrate a capillary gel electrophoresis (CGE)-based multidimensional protein separation platform, capable of providing significant analyte concentration and extremely high resolving power for handling complex protein mixtures prior to mass spectrometry detection. In comparison with conventional SDS-PAGE-based proteome approaches, the proposed CGE/nano-reversed-phase liquid chromatography proteome technology will be highly automated and offer robust and high throughput fractionation of whole proteins for top-down proteomics while avoiding analyte dilution and loss in an integrated platform. By coupling with a nanoscale trypsin membrane reactor, the ultrafast proteolytic digestion of proteins resolved and eluted from the CGE-based separations enables the combined top-down/bottom-up characterization of PTMs in mouse liver mitochondria as the model system in this study.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R43
  • Administering IC
    AG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99878
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
    NIA:99878\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CALIBRANT BIOSYSTEMS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    Gaithersburg
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20878
  • Organization District
    UNITED STATES